Abbott to cut 700 jobs in Temecula
Abbott Laboratories said today it will cut 700 jobs at its Temecula stent factory, about 15 percent of its workforce there, and will close its stent facility in Ireland.
The Temecula plant employs about 4,500 people, spokeswoman Karin Bauer said.
I read an article in my wife’s “Healthy Living” magazine recently that claimed stents are bad news. There was no proof that they worked better than drugs alone and some evidence that they are dangerous. That may have something to do with it.
I read an article in my wife’s “Healthy Living” magazine recently that claimed stents are bad news. There was no proof that they worked better than drugs alone and some evidence that they are dangerous. That may have something to do with it.
I read an article in my wife’s “Healthy Living” magazine recently that claimed stents are bad news. There was no proof that they worked better than drugs alone and some evidence that they are dangerous. That may have something to do with it.
I read an article in my wife’s “Healthy Living” magazine recently that claimed stents are bad news. There was no proof that they worked better than drugs alone and some evidence that they are dangerous. That may have something to do with it.
I read an article in my wife’s “Healthy Living” magazine recently that claimed stents are bad news. There was no proof that they worked better than drugs alone and some evidence that they are dangerous. That may have something to do with it.
Stents, particularly the new-fangled drug coated variety, have gotten some bad press over the past few years. I’ve been tuned in because my uncle has one and my girl is in the med device industry. Stent sales are way off and I believe Abbott was looking to score big in the drug-coated stent category. Their new stent just got approved by an FDA panel (but not the by FDA, not yet).
Stents, particularly the new-fangled drug coated variety, have gotten some bad press over the past few years. I’ve been tuned in because my uncle has one and my girl is in the med device industry. Stent sales are way off and I believe Abbott was looking to score big in the drug-coated stent category. Their new stent just got approved by an FDA panel (but not the by FDA, not yet).
Stents, particularly the new-fangled drug coated variety, have gotten some bad press over the past few years. I’ve been tuned in because my uncle has one and my girl is in the med device industry. Stent sales are way off and I believe Abbott was looking to score big in the drug-coated stent category. Their new stent just got approved by an FDA panel (but not the by FDA, not yet).
Stents, particularly the new-fangled drug coated variety, have gotten some bad press over the past few years. I’ve been tuned in because my uncle has one and my girl is in the med device industry. Stent sales are way off and I believe Abbott was looking to score big in the drug-coated stent category. Their new stent just got approved by an FDA panel (but not the by FDA, not yet).
Stents, particularly the new-fangled drug coated variety, have gotten some bad press over the past few years. I’ve been tuned in because my uncle has one and my girl is in the med device industry. Stent sales are way off and I believe Abbott was looking to score big in the drug-coated stent category. Their new stent just got approved by an FDA panel (but not the by FDA, not yet).
